Skip to main content

Table 4 Results of heterogeneity and publication bias estimation and subgroup meta-analysis for prevalence of gestational diabetes based on various GDM screening threshold group among pregnant women in different geographic regions

From: The impact of diagnostic criteria for gestational diabetes on its prevalence: a systematic review and meta-analysis

Regions

GDM diagnostic threshold subgroup

Number of studies included

Begg’s test

P-value

I2%

Pooled measure of GDM (95% CI)

A

1

1

–

–

0.058 (0.039–0.076)

2

–

–

–

–

3

1

–

–

0.076 (0.072–0.080)

4

–

–

–

–

5

9

0.602

99

0.054 (0.054–0.054)

6

6

0.851

98

0.029 (0.028–0.029)

7

1

–

–

0.017 (0.016–0.019)

Overall

18

0.692

99

0.045 (0.044–0.045)

B

1

6

0.850

99

0.152 (0.147–0.157)

2

–

–

–

–

3

5

0.625

99

0.094 (0.090–0.097)

4

–

–

–

–

5

–

–

–

–

6

–

–

–

–

7

–

–

–

–

Overall

11

0.258

99

0.114 (0.111–0.117)

C

1

–

–

–

–

2

7

0.625

99

0.036 (0.036–0.037)

3

–

–

–

–

4

–

–

–

–

5

–

–

–

–

6

–

–

–

–

7

–

–

–

–

Overall

7

0.625

99

0.036 (0.036–0.037)

D

1

4

0.090

99

0.078 (0.076–0.081)

2

1

–

–

0.045 (0.044–0.046)

3

–

 

–

–

4

–

 

–

–

5

2

0.317

99

0.053 (0.050–0.056)

6

–

–

–

–

7

2

0.317

91

0.072 (0.070–0.075)

Overall

9

0.051

99

0.055 (0.054–0.056)

E

1

7

0.293

99

0.108 (0.107–0.108)

2

–

–

–

–

3

2

0.317

98

0.194 (0.175–0.213)

4

2

0.317

0

0.022 (0.022–0.023)

5

–

–

–

–

6

–

–

–

–

7

1

–

–

0.012 (0.009–0.015)

Overall

12

0.520

100

0.060 (0.059–0.060)

  1. A: USA and Canada; B: South Asia including India, Bangladesh and Sri Lanka; C: Australia; D: East Asia including China and Japan; E: north Europe including Finland, Ireland, Sweden, Norway and Germany